The South Korean spatial biology company unveils new AI agents, foundation models, and spatial biomarkers for oncology drug discovery. SEOUL, South Korea, /PRNewswire/ -- Portrai, Inc. today announced ...
SEOUL, South Korea, April 8, 2026 /PRNewswire/ -- Portrai, Inc. today announced it will present 11 posters highlighting its artificial intelligence and spatial transcriptomics capabilities at the ...
PLEASANTON, Calif., April 18, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...
Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the ...
As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...
This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...
ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the presentation of ...
Researchers from The University of Texas MD Anderson Cancer Center will present breakthrough studies at the American Association for Cancer Research (AACR) Annual Meeting 2026.
Penn Medicine researchers will present advances in CAR T cell therapy, cancer interception, prevention, and more at the 2026 AACR Annual Meeting.
Nicotine, a potent insecticidal alkaloid unique to the nightshade family, has been employed in agriculture as a pesticide ...